Future Science Group
Supplementary Figure 1.jpg (46.48 kB)

Pathologically complete remission to combination of iNKT cells and anti-CD20 antibody in a refractory HIV+ DLBCL patient. Supplementary Figure 1

Download (46.48 kB)
posted on 2022-04-21, 06:05 authored by Jianqing Xu, xiaoyan zhang, Zhenyan Wang, Wei Song, Huiliang Hu, Qibin Liao, Bili Xia, Ran Qin, Yanling Jin, Xiangqing Ding, Renfang Zhang, Jing Wang

 Anti-tumor activity of iNKT cells combined with modified anti-CD20 antibody was evaluated in vitro and in mice model